ArticleCancers2025

Correction: Mancuso et al. Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma.

Katia Mancuso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.